198 related articles for article (PubMed ID: 15976377)
1. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.
Borczuk AC; Kim HK; Yegen HA; Friedman RA; Powell CA
Am J Respir Crit Care Med; 2005 Sep; 172(6):729-37. PubMed ID: 15976377
[TBL] [Abstract][Full Text] [Related]
2. Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.
Borczuk AC; Papanikolaou N; Toonkel RL; Sole M; Gorenstein LA; Ginsburg ME; Sonett JR; Friedman RA; Powell CA
Oncogene; 2008 Jan; 27(4):557-64. PubMed ID: 17653092
[TBL] [Abstract][Full Text] [Related]
3. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.
Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA
Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454
[TBL] [Abstract][Full Text] [Related]
4. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
5. Global gene expression differentiating pure bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar carcinoma features.
Zhang WC; Zhang ZF; You J; Wang CL
Eur J Cardiothorac Surg; 2013 Apr; 43(4):765-71. PubMed ID: 22864788
[TBL] [Abstract][Full Text] [Related]
6. Tgf-beta signaling pathway in lung adenocarcinoma invasion.
Toonkel RL; Borczuk AC; Powell CA
J Thorac Oncol; 2010 Feb; 5(2):153-7. PubMed ID: 20101143
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
[TBL] [Abstract][Full Text] [Related]
8. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
9. [Distribution of transforming growth factor-beta and its receptor in bronchiolo-alveolar cell hyperplasia and bronchiolo-alveolar carcinoma].
Zeng Q; Jiang H; Yan Y; Qian Z
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):345-8. PubMed ID: 11189389
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
[TBL] [Abstract][Full Text] [Related]
11. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
12. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
[TBL] [Abstract][Full Text] [Related]
13. STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.
Takata S; Takigawa N; Segawa Y; Kubo T; Ohashi K; Kozuki T; Teramoto N; Yamashita M; Toyooka S; Tanimoto M; Kiura K
Lung Cancer; 2012 Jan; 75(1):24-9. PubMed ID: 21684622
[TBL] [Abstract][Full Text] [Related]
14. Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features.
Aviel-Ronen S; Coe BP; Lau SK; da Cunha Santos G; Zhu CQ; Strumpf D; Jurisica I; Lam WL; Tsao MS
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10155-60. PubMed ID: 18632575
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
16. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive adenocarcinomas of the lung.
Dacic S
Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
[TBL] [Abstract][Full Text] [Related]
18. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
[TBL] [Abstract][Full Text] [Related]
19. Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential.
Machida Y; Ueda Y; Shimasaki M; Sato K; Sagawa M; Katsuda S; Sakuma T
Hum Pathol; 2011 May; 42(5):669-78. PubMed ID: 21237499
[TBL] [Abstract][Full Text] [Related]
20. [Advance in pulmonary adenocarcinoma with micropapillary pattern].
ZHANG J; LIANG ZY; LIU TH
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):202-5. PubMed ID: 21575400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
